RwHealth, the Artificial Intelligence provider for the NHS, promises to transform healthcare

Partner Content
RwHealth, the Artificial Intelligence provider for the NHS

RwHealth, the leading provider of Artificial Intelligence to the healthcare industry, has today reported 160 per cent year-on-year growth as its data-led solutions are increasingly embraced by NHS trusts, private healthcare providers and major pharmaceutical companies.

RwHealth’s unique Data Science Platform combines Artificial Intelligence (AI), Machine Learning and Data Science to give healthcare providers access to the best and most in-depth data available, helping them to make better decisions, at speed, and improve outcomes for their patients. By using RwHealth’s deep analytical capability to make predictions, model treatment options, improve safety and increase efficiency, clinicians can deliver better care to more people. 

One important capability driving the company’s significant growth in the last twelve months is its ability to anticipate patient flow in hospitals. Being able to model patient numbers has been vital during the Covid pandemic, and the RwHealth platform has helped many of the UK’s hospitals to anticipate demand and help combat bed shortages - as well as tackling waiting list issues which have worsened during the pandemic.

RwHealh’s success mirrors the wider growth of AI in healthcare, as stakeholders across the health ecosystem try to find new ways to increase efficiency, save money and deliver optimised clinical outcomes at speed. In September 2020, NHSX, the organisation driving the digital transformation of health and social care, announced a £250 million investment into injecting more AI technology into UK healthcare.

Orlando Agrippa, CEO and Founder of RwHealth, said: “We’ve grown at an extraordinary rate, as healthcare providers realise how AI can effectively improve patient level outcomes, while helping to ease the wider pressures that the healthcare industry currently faces. It’s important, now more than ever, to tackle backlogs and bed capacity issues so that healthcare remains safe, steady and consistent as we all attempt to recover post-Covid.”

RwHealth client, Chief Medical Officer (interim) and Responsible Officer Andrew McLaren, adds: “RwHealth’s platform enables us to see and solve bottlenecks before they become a problem -  everything we do in cancer treatment is an exercise in saving time. Faster treatment leads to better outcomes, so every moment the solution helps us save – no matter how small – has tangible impact on patient care.”

Security and the protection of patient data is at the heart of the RwHealth proposition. While its primary customers are NHS Trusts and private healthcare organisations, the company does not hold any private patient information nor any personally identifiable hospital data. With a dedicated Data Protection Officer, RwHealth use suitable technical and operational safeguards to protect all information from unauthorised access, use/misuse and changes.

RwHealth works with more 70 providers in the UK and internationally, its AI technology having processed more than 10 million patients in the UK and a further 5.5 million across the Middle East and Australia.

21 September, 2021



Card image cap

Sanofi, CytoReason expand AI deal into IBD

Tech company CytoReason has announced it has signed a multi-year, multimillion dollar deal with Sanofi to deliver artificial intelligence (AI) for drug discovery and development in the fiel